US 8309566
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
granted A61PA61P29/00A61P35/00
Quick answer
US patent 8309566 (Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases) held by Rigel Pharmaceuticals, Inc. expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P29/00, A61P35/00, A61P35/02, A61P37/06